978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV

BACKGROUND: A potential association between integrase inhibitor (INSTI) use and weight gain has been reported in people living with HIV (PLWH). We examined body mass index (BMI) increases after a switch to dolutegravir (DTG), elvitegravir/cobicistat (EVG/c), raltegravir (RAL), rilpivirine (RPV), or...

Descripción completa

Detalles Bibliográficos
Autores principales: Mounzer, Karam, Brunet, Laurence, Hsu, Ricky, Fatukasi, Terra, Fusco, Jennifer S, Vannappagari, Vani, Henegar, Cassidy, van Wyk, Jean A, Crawford, Melissa, Lo, Janet, Fusco, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809375/
http://dx.doi.org/10.1093/ofid/ofz359.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809375/
http://dx.doi.org/10.1093/ofid/ofz359.080

Ejemplares similares